Long term obesity drug use could hurt the food industry, says Morgan Stanley’s Pam Kaufman

Pam Kaufman, equity research analyst at Morgan Stanley, joins ‘The Exchange’ to discuss the impact of obesity drugs on the food and beverage sector, what companies might be hurt by a possible pullback in appetite brought on by obesity drug use and what food companies could benefit from a shift in consumer eating habits.